These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3723187)

  • 1. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
    McLean RG; Ege GN
    J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraoperative lymphoscintigraphy in radical surgery of cancer].
    Gitsch E; Philipp K; Kubista E
    Geburtshilfe Frauenheilkd; 1983 Feb; 43(2):112-5. PubMed ID: 6551291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary lymphoscintigraphy in breast cancer.
    Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
    J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting nodal metastases in breast cancer by lymphoscintigraphy.
    Hill NS; Ege GN; Greyson ND; Mahoney LJ; Jirsch DW
    Can J Surg; 1983 Nov; 26(6):507-9. PubMed ID: 6627140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of breast lymphoscintigraphy in the definition of axillary staging in cancer of the breast].
    Serin D; Vinot JM; Martin P; Reboul F; Robin M; Chevallier J
    Bull Cancer; 1986; 73(3):299-304. PubMed ID: 3756366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High colloidal uptake in axillary nodes with metastatic disease.
    Peyton JW; Crosbie J; Bell TK; Roy AD; Odling-Smee W
    Br J Surg; 1981 Jul; 68(7):507-9. PubMed ID: 7248724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoscintigraphy in staging and management of breast cancer.
    Nisa L; Hussain F; Yasmin S; Afroj K
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):8-14. PubMed ID: 11192493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.
    Wanebo HJ; Harpole D; Teates CD
    Cancer; 1985 Mar; 55(6):1403-13. PubMed ID: 3971311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New simplified lymphoscintigraphic technique in patients with breast cancer.
    Terui S; Yamamoto H
    J Nucl Med; 1989 Jul; 30(7):1198-204. PubMed ID: 2738701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can preoperative lymphoscintigraphy be used as a guide in treatment planning of breast cancer?
    Mudun A; Aslay I; Aygen M; Muslumanoglu M; Bozfakioglu Y; Cantez S
    Clin Nucl Med; 2001 May; 26(5):405-11. PubMed ID: 11317020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymphoscintigraphy.
    Ege GN
    Br J Surg; 1982 Feb; 69(2):116-7. PubMed ID: 7059768
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoscintigraphy and the intraoperative gamma probe.
    Alazraki N
    J Nucl Med; 1995 Oct; 36(10):1780-3. PubMed ID: 7562042
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoscintigraphy--techniques and applications in the management of breast carcinoma.
    Ege GN
    Semin Nucl Med; 1983 Jan; 13(1):26-34. PubMed ID: 6836316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of axillary metastases in breast cancer by lymphoscintigraphy.
    Black RB; Merrick MV; Taylor TV; Forrest AP
    Lancet; 1980 Jul; 2(8184):15-7. PubMed ID: 6104225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of axillary lymphoscintigraphy in the diagnosis of breast cancer.
    Ege Gn
    Clin Oncol; 1981 Sep; 7(3):262-3. PubMed ID: 7343171
    [No Abstract]   [Full Text] [Related]  

  • 16. The relevance of internal mammary lymphoscintigraphy in the management of breast carcinoma.
    Ege GN; Elhakim T
    J Clin Oncol; 1984 Jul; 2(7):774-81. PubMed ID: 6737019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication.
    Kaplan WD; Davis MA; Rose CM
    J Nucl Med; 1979 Sep; 20(9):933-7. PubMed ID: 536838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer of the breast: the return of lymphoscintigraphy?].
    Pourquier D; Lemanski C; Faurous P; Couty H; Delard R; Rouanet P; Dubois JB
    Bull Cancer; 1998 Aug; 85(8):675-84. PubMed ID: 9754076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.
    Kaplan WD; Piez CW; Gelman RS; Laffin SM; Rosenbaum EM; Jennings CA; McCormick CA; Harris JR; Henderson IC; Atkins HL
    J Nucl Med; 1985 Dec; 26(12):1382-5. PubMed ID: 4067640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.